Stock Analysis on Net
Stock Analysis on Net

Abbott Laboratories (NYSE:ABT)

$24.99

Income Statement

The income statement presents information on the financial results of a company business activities over a period of time. The income statement communicates how much revenue the company generated during a period and what cost it incurred in connection with generating that revenue.

Paying user area

Try for free

Abbott Laboratories pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Abbott Laboratories, consolidated income statement

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net sales
Cost of products sold, excluding amortization of intangible assets
Amortization of intangible assets
Gross profit
Research and development
Selling, general and administrative
Operating earnings
Interest expense
Interest income
Net foreign exchange gain (loss)
Debt extinguishment costs
Other income (expense), net
Earnings from continuing operations before taxes
Taxes on earnings from continuing operations
Earnings from continuing operations
Net earnings from discontinued operations, net of taxes
Net earnings

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Income statement item Description The company
Net sales Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Abbott Laboratories net sales increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Operating earnings The net result for the period of deducting operating expenses from operating revenues. Abbott Laboratories operating earnings decreased from 2021 to 2022 and from 2022 to 2023.
Earnings from continuing operations before taxes Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Abbott Laboratories earnings from continuing operations before taxes increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Net earnings The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Abbott Laboratories net earnings decreased from 2021 to 2022 and from 2022 to 2023.